Baystreet.ca - Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug ...

Related Keywords

Hackensack ,New Jersey ,United States ,Canada ,Canadian ,Americans ,Beckley Psytech ,Amy Emerson ,Rob Barrow ,Michael Tan ,Payton Nyquvest ,Rick Doblin ,Numinus Wellness Inc ,Drug Administration ,Cedar Clinical Research ,Public Benefit Corporation ,Multidisciplinary Association For Psychedelic ,Life Sciences ,University Hospital Basel ,Hackensack Meridian Health ,New Drug Application ,Lykos Therapeutics ,Numinus Wellness ,Compass Pathways ,Seelos Therapeutics ,Mind Medicine ,Strong Catalyst ,Wellness Inc ,Multidisciplinary Association ,Psychedelic Studies ,Benefit Corporation ,Prescription Drug User Fee Act ,Numinus Founder ,Numinus Strategic Advisor ,Depression Rating Scale ,Beckley Psytech Limited ,Winning Media ,